当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第6期
编号:13321887
肠道菌群在非酒精性脂肪性肝病发病机制中的作用(7)
http://www.100md.com 2019年2月25日 《中国现代医生》 2019年第6期
     [50] Henaomejia J,Elinav E,Jin C,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J]. Nature,2012,482(7384):179-185.

    [51] Laura D,Michael B,Samjhana T,et al. Caspase 1-mediated regulation of fibrogenesis in diet-induced steatohepatitis[J]. Laboratory Investigation; A Journal of Technical Methods and Pathology,2012,92(5):713.

    [52] O?Sullivan TA,Oddy WH,Bremner AP,et al. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity[J]. Journal of Pediatric Gastroenterology & Nutrition,2014, 58(5):624.

    [53] Moore JB,Gunn PJ,Fielding BA. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease[J]. Nutrients,2014,6(12):5679-5703.

    [54] Jin R,Willment A,Patel SS,et al. Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease[J].International Journal of Hepatology,2014,2014(8):560620.

    [55] Jegatheesan P,Beutheu S,Ventura G,et al. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease[J]. Clinical Nutrition,2016,35(1):175-182.

    [56] Wagnerberger S,Spruss A,Kanuri G, et al. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis[J]. British Journal of Nutrition,2012, 107(12):1727-1738., 百拇医药(柳惠未 叶桦)
上一页1 2 3 4 5 6 7